• 英文論文
• 英文著書
• 和文論文
• 和文著書

英文論文 31〜40

1. Clin Cancer Res 6: 1229-38, 2000.    Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus      Shamma A, Yamamoto H, Doki Y, Okami J, Kondo M, Fujiwara Y, Yano M, Inoue M, Matsuura N, Shiozaki H, Monden M
   
   
   
2. Oncol 58: 248-52, 2000.    ets-i expression in extrahepatic bile duct carcinoma and cholangiocellular carcinoma      Ito Y, Miyoshi E, Takeda T, Sakon M, Tsujimoto M, Yokosaki Y, Monden M, Matsuura N
   
   
   
3. Anticancer Res 20: 1999-2003, 2000.    Fas-Fas ligand pathway does not actively work in extrahepatic bile duct carcinoma      Ito Y, Takeda T, Sakon M, Tsujimoto M, Matsuura N
   
   
   
4. Oncology 59: 68-74, 2000.    Expression and Prognostic Role of Cyclin-Dependent Kinase 1 (cdc2) in Hepatocellular Carcinoma      Ito Y, Takeda T, Sakon M, Monden M, Tsujimoto M, Matsuura N
   
   
   
5. Oncology 59: 63-7, 2000.    bcl-2 Expression in Cholangiocellular Carcinoma Is Inversely Correlated with Biologically Aggressive Phenotypes      Ito Y, Takeda T, Sasaki Y, Sakon M, Monden M, Yamada T, Ishiguro S, Imaoka S, Tsujimoto M, Matsuura N
   
   
   
6. Clin Cancer Res 6: 2326-32, 2000.    Genetic detection for micrometastasis in lymph node of biliary tract carcinoma      Okami J, Dohno K, Sakon M, Iwao K, Yamada T, Yamamoto H, Fujiwara Y, Nagano H, Umeshita K, Matsuura N, Nakamori S, Monden M
   
   
   
7. Cancer Res 60: 3043-50, 2000.    Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma      Takemasa I, Yamamoto H, Sekimoto M, Ohue M, Noura S, Miyake Y, Matsumoto T, Aihara T, Tomita N, Tamaki Y, Sakita I, Kikkawa N, Matsuura N, Shiozaki H, Monden M
   
   
   
8. Digest Dis Sci　45: 1383-8, 2000.    Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by post-hepatectomy liver failure      Eguchi H, Umeshita K, Sakon M, Nagano H, Ito Y, Kishimoto S, Dono K, Nakamori S, Takeda T, Gotoh M, Wakasa K, Matsuura N, Monden M
   
   
   
9. Anticancer Res 20: 3891-5, 2000.    Expression and clinical implications of bcl-2 in extrahepatic bile duct carcinoma; its relationship with biological features      Ito Y, Takeda T, Sakon M, Tsujimoto M, Matsuura N
   
   
   
10. Int J Mol Med 6: 581-6, 2000.    Expression of Fas and Fas ligand reflects the biological characteristics but not the status of apoptosis of intrahepatic cholangiocellular carcinoma      Ito Y, Takeda T, Sasaki Y, Sakon M, Yamada T, Ishiguro S, Imaoka S, Tsujimoto M, Matsuura N